Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

61509 1497862462HCLSReviewTaiwanJune2017.pdf
Energy Boardroom

Chinese drugmaker plots $761M stock offering to fund deals, R&D

23.06.2014 / Fierce Pharma

China's Luye Pharma Group wants to step up its game–and some of its key investors want to cash out. So, it's planning an initial public offering in Hong Kong worth up to HK$5.9 billion, or about $761 million.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: